Superficial parotid lobe-sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma

被引:15
作者
Zhang, H. B. [1 ]
Lu, X. [1 ]
Huang, S. M. [2 ]
Wang, L. [1 ]
Zhao, C. [2 ]
Xia, W. X. [1 ]
Li, S. W. [1 ]
Wang, F. L. [1 ]
Zhu, Y. L. [1 ]
Guo, X. [1 ]
Xiang, Y. Q. [1 ]
机构
[1] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Radiotherapy, Guangzhou 510060, Guangdong, Peoples R China
关键词
Intensity-modulated radiotherapy; nasopharyngeal carcinoma; superficial parotid lobes; QUALITY-OF-LIFE; NECK-CANCER; SALIVARY FUNCTION; HEAD; SCINTIGRAPHY; VOLUME; IMRT;
D O I
10.3747/co.20.1485
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose We used a superficial parotid lobe-sparing delineation approach for dose optimization with better protection for the parotid glands in intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC) patients. Methods Compared with traditional contouring of the entire parotid glands as organs at risk (OARS) in IMRT for NPC, we used a superficial parotid lobe-sparing delineation approach of contouring the superficial parotid lobes as oars. Changes in dose to the parotid glands, the targets, and other OARS were evaluated. Results The mean dose to the parotid glands overall decreased by more than 4 Gy in the test plans. Impressively, the mean dose to the superficial parotid lobes in the test plans was not more than 30 Gy, regardless of clinical stage. In T1-3 NPC patients, the dose distributions for targets were not significantly different in the control plans and the test plans. However, for some T4 patients, the dose distributions for targets and brainstem in the test plans could not meet clinical requirements. Conclusions The superficial parotid lobe-sparing delineation approach can significantly lower the mean dose to the entire parotid and to the superficial parotid lobe in T1-3 NPC patients, which would be expected to result in less xerostomia and better quality of life for those patients.
引用
收藏
页码:E577 / E584
页数:8
相关论文
共 21 条
[1]   Quality of life and head and neck cancer: A 5 year prospective study [J].
Abendstein, H ;
Nordgren, M ;
Boysen, M ;
Jannert, M ;
Silander, E ;
Ahlner-Elmqvist, M ;
Hammerlid, E ;
Bjordal, K .
LARYNGOSCOPE, 2005, 115 (12) :2183-2192
[2]   A prospective study of quality of life in head and neck cancer patients.: Part II:: Longitudinal data [J].
Bjordal, K ;
Ahlner-Elmqvist, M ;
Hammerlid, E ;
Boysen, M ;
Evensen, JF ;
Biörklund, A ;
Jannert, M ;
Westin, T ;
Kaasa, S .
LARYNGOSCOPE, 2001, 111 (08) :1440-1452
[3]   Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy [J].
Blanco, AI ;
Chao, KSC ;
El Naqa, I ;
Franklin, GE ;
Zakarian, K ;
Vicic, M ;
Deasy, JO .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (04) :1055-1069
[4]   Intensity-modulated radiotherapy: Is xerostomia still prevalent? [J].
Chambers M.S. ;
Garden A.S. ;
Rosenthal D. ;
Ahamad A. ;
Schwartz D.L. ;
Blanco A.I. ;
Chao K.S.C. ;
Morrison W.H. ;
Ang K.K. ;
Weber R.S. .
Current Oncology Reports, 2005, 7 (2) :131-136
[5]   A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma [J].
Chau, R. M. C. ;
Leung, S. F. ;
Kam, M. K. M. ;
Cheung, K. Y. ;
Kwan, W. H. ;
Yu, K. H. ;
Chiu, S. K. W. ;
Chan, A. T. C. .
CLINICAL ONCOLOGY, 2008, 20 (02) :134-141
[6]   A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy [J].
de Graeff, A ;
de Leeuw, JRJ ;
Ros, WJG ;
Hordijk, GJ ;
Blijham, GH ;
Winnubst, JAM .
ORAL ONCOLOGY, 1999, 35 (01) :27-32
[7]   Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer [J].
Eisbruch, A ;
Ten Haken, RK ;
Kim, HM ;
Marsh, LH ;
Ship, JA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (03) :577-587
[8]   PAROTID-GLAND FUNCTION DURING AND FOLLOWING RADIOTHERAPY OF MALIGNANCIES IN THE HEAD AND NECK - A CONSECUTIVE STUDY OF SALIVARY FLOW AND PATIENT DISCOMFORT [J].
FRANZEN, L ;
FUNEGARD, U ;
ERICSON, T ;
HENRIKSSON, R .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :457-462
[9]   Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms [J].
Hammerlid, E ;
Taft, C .
BRITISH JOURNAL OF CANCER, 2001, 84 (02) :149-156
[10]  
Hammerlid E, 2001, HEAD NECK-J SCI SPEC, V23, P113, DOI 10.1002/1097-0347(200102)23:2<113::AID-HED1006>3.0.CO